-
1
-
-
67349216357
-
Autoimmune T-cell responses in the central nervous system
-
Goverman J. Autoimmune T-cell responses in the central nervous system. Nat Rev Immunol 2009; 9: 393-407.
-
(2009)
Nat Rev Immunol
, vol.9
, pp. 393-407
-
-
Goverman, J.1
-
2
-
-
65649096159
-
Localizing central nervous system immune surveillance: Meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis
-
Kivisäkk P, Imitola J, Rasmussen S, et al. Localizing central nervous system immune surveillance: Meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann Neurol 2009; 65: 457-469.
-
(2009)
Ann Neurol
, vol.65
, pp. 457-469
-
-
Kivisäkk, P.1
Imitola, J.2
Rasmussen, S.3
-
3
-
-
0342906187
-
Heterogeneity of multiple sclerosis lesions: Implications for pathogenesis of demyelination
-
Lucchinetti C, Brück W, Prisi J, et al. Heterogeneity of multiple sclerosis lesions: Implications for pathogenesis of demyelination. Ann Neurol 2000; 47: 707-717.
-
(2000)
Ann Neurol
, vol.47
, pp. 707-717
-
-
Lucchinetti, C.1
Brück, W.2
Prisi, J.3
-
4
-
-
0344961161
-
Blood-brain Barrier disruption in multiple sclerosis
-
Minagar A and Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler 2003; 9: 540-549.
-
(2003)
Mult Scler
, vol.9
, pp. 540-549
-
-
Minagar, A.1
Alexander, J.S.2
-
5
-
-
84859540194
-
Multiple sclerosis
-
Miller E. Multiple sclerosis. Adv Exp Med Biol 2012; 724: 222-238.
-
(2012)
Adv Exp Med Biol
, vol.724
, pp. 222-238
-
-
Miller, E.1
-
6
-
-
84884592784
-
Pathophysiology of the brain extracellular matrix: A new target for remyelination
-
Lau LW, Cua R, Keough MB, et al. Pathophysiology of the brain extracellular matrix: A new target for remyelination. Nat Rev Neurosci 2013; 14: 722-729.
-
(2013)
Nat Rev Neurosci
, vol.14
, pp. 722-729
-
-
Lau, L.W.1
Cua, R.2
Keough, M.B.3
-
7
-
-
84855881970
-
Serum levels of matrix metalloproteinases: Implications in clinical neurology
-
Romi F, Helgeland G and Gilhus NE. Serum levels of matrix metalloproteinases: Implications in clinical neurology. Eur Neurol 2012; 67: 121-128.
-
(2012)
Eur Neurol
, vol.67
, pp. 121-128
-
-
Romi, F.1
Helgeland, G.2
Gilhus, N.E.3
-
8
-
-
0037693895
-
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function and biochemistry
-
Visse R and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function and biochemistry. Circ Res 2003; 92: 827-839.
-
(2003)
Circ Res
, vol.92
, pp. 827-839
-
-
Visse, R.1
Nagase, H.2
-
9
-
-
58249126857
-
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases
-
Rosenberg GA Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009; 8: 205-216.
-
(2009)
Lancet Neurol
, vol.8
, pp. 205-216
-
-
Rosenberg, G.A.1
-
10
-
-
36849094431
-
Matrix metalloproteinases as modulators of inflammation
-
Manicone AM and McGuire JK. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 2008; 19: 34-41.
-
(2008)
Semin Cell Dev Biol
, vol.19
, pp. 34-41
-
-
Manicone, A.M.1
McGuire, J.K.2
-
11
-
-
0031798063
-
Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis
-
Leppert D, Ford J, Stabler G, et al. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 1998; 121: 2327-2334.
-
(1998)
Brain
, vol.121
, pp. 2327-2334
-
-
Leppert, D.1
Ford, J.2
Stabler, G.3
-
12
-
-
0032948343
-
Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study
-
Lee MA, Palace J, Stabler G, et al. Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. Brain 1999; 122: 191-197.
-
(1999)
Brain
, vol.122
, pp. 191-197
-
-
Lee, M.A.1
Palace, J.2
Stabler, G.3
-
13
-
-
0032693982
-
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis
-
Waubant E, Goodkin DE, Gee L, et al. Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology 1999; 53: 1397-1401.
-
(1999)
Neurology
, vol.53
, pp. 1397-1401
-
-
Waubant, E.1
Goodkin, D.E.2
Gee, L.3
-
14
-
-
0033622321
-
CCRΔ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis
-
Sellebjerg F, Madsen HO, Jensen CV, et al. CCRΔ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis. J Neuroimmunol 2000; 102: 98-106.
-
(2000)
J Neuroimmunol
, vol.102
, pp. 98-106
-
-
Sellebjerg, F.1
Madsen, H.O.2
Jensen, C.V.3
-
15
-
-
0035989120
-
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: Implication for pathogenesis
-
Liuzzi GM, Trojano M, Fanelli M, et al. Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: Implication for pathogenesis. Mult Scler 2002; 8: 222-228.
-
(2002)
Mult Scler
, vol.8
, pp. 222-228
-
-
Liuzzi, G.M.1
Trojano, M.2
Fanelli, M.3
-
16
-
-
0037333750
-
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes
-
Avolio C, Ruggieri M, Giuliani F, et al. Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes. J Neuroimmunol 2003; 136: 46-53.
-
(2003)
J Neuroimmunol
, vol.136
, pp. 46-53
-
-
Avolio, C.1
Ruggieri, M.2
Giuliani, F.3
-
17
-
-
61849164425
-
Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis
-
Benesová Y, Vasku A, Novotná H, et al. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis. Mult Scler 2009; 15: 316-322.
-
(2009)
Mult Scler
, vol.15
, pp. 316-322
-
-
Benesová, Y.1
Vasku, A.2
Novotná, H.3
-
18
-
-
77955022345
-
Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b
-
Alexander JS, Harris MK, Wells SR, et al. Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b. Mult Scler 2010; 16: 801-809.
-
(2010)
Mult Scler
, vol.16
, pp. 801-809
-
-
Alexander, J.S.1
Harris, M.K.2
Wells, S.R.3
-
19
-
-
33744811943
-
Cerebrospinal fluid and serum levels, and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis
-
Fainardi E, Castellazzi M, Bellini T, et al. Cerebrospinal fluid and serum levels, and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Mult Scler 2006; 12: 294-301.
-
(2006)
Mult Scler
, vol.12
, pp. 294-301
-
-
Fainardi, E.1
Castellazzi, M.2
Bellini, T.3
-
20
-
-
84860463028
-
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms
-
Bellini T, Trentini A, Manfrinato MC, et al. Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms. J Biochem 2012; 151: 493-499.
-
(2012)
J Biochem
, vol.151
, pp. 493-499
-
-
Bellini, T.1
Trentini, A.2
Manfrinato, M.C.3
-
21
-
-
0026795140
-
Matrix metalloproteinase 9 (92-kDa gelatinase/Type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties
-
Okada Y, Gonoji Y, Naka K, et al. Matrix metalloproteinase 9 (92-kDa gelatinase/Type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 1992; 267: 21712-21719.
-
(1992)
J Biol Chem
, vol.267
, pp. 21712-21719
-
-
Okada, Y.1
Gonoji, Y.2
Naka, K.3
-
22
-
-
0026660964
-
Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9
-
Ogata Y, Enghild JJ and Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 1992; 267: 3581-3584.
-
(1992)
J Biol Chem
, vol.267
, pp. 3581-3584
-
-
Ogata, Y.1
Enghild, J.J.2
Nagase, H.3
-
23
-
-
38049136866
-
A biochemical model of matrix metalloproteinase 9 activation and inhibition
-
Vempati P, Karagiannis ED and Popel AS. A biochemical model of matrix metalloproteinase 9 activation and inhibition. J Biol Chem 2007; 282: 37585-37596.
-
(2007)
J Biol Chem
, vol.282
, pp. 37585-37596
-
-
Vempati, P.1
Karagiannis, E.D.2
Popel, A.S.3
-
24
-
-
84893700542
-
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants
-
Rossano R, Larocca M, Riviello L, et al. Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants. J Cell Mol Med 2014; 18: 242-252.
-
(2014)
J Cell Mol Med
, vol.18
, pp. 242-252
-
-
Rossano, R.1
Larocca, M.2
Riviello, L.3
-
25
-
-
0034955141
-
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
-
McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121-127.
-
(2001)
Ann Neurol
, vol.50
, pp. 121-127
-
-
McDonald, W.I.1
Compston, A.2
Edan, G.3
-
26
-
-
0029913882
-
Defining the clinical course of multiple sclerosis: Results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis
-
Lublin FD and Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-911.
-
(1996)
Neurology
, vol.46
, pp. 907-911
-
-
Lublin, F.D.1
Reingold, S.C.2
-
27
-
-
0020686503
-
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
-
Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
-
(1983)
Ann Neurol
, vol.13
, pp. 227-231
-
-
Poser, C.M.1
Paty, D.W.2
Scheinberg, L.3
-
28
-
-
0027381828
-
Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis
-
Miller DH, Barkhof F and Nauta JJP. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 1993; 116: 1077-1094.
-
(1993)
Brain
, vol.116
, pp. 1077-1094
-
-
Miller, D.H.1
Barkhof, F.2
Nauta, J.J.P.3
-
29
-
-
80054933935
-
Detection of functional matrix metalloproteinases by zymography
-
Hu X and Beeton C. Detection of functional matrix metalloproteinases by zymography. J Vis Exp 2010: 1-4.
-
J Vis Exp
, vol.2010
, pp. 1-4
-
-
Hu, X.1
Beeton, C.2
-
30
-
-
84899793854
-
Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain Barrier
-
Shimizu F, Tasaki A, Sano Y, et al. Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier. PLoS One 2014; 9: e92872.
-
(2014)
PLoS One
, vol.9
-
-
Shimizu, F.1
Tasaki, A.2
Sano, Y.3
-
31
-
-
32344445287
-
Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis
-
Kanesaka T, Mori M, Hattori T, et al. Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2006; 77: 185-188.
-
(2006)
J Neurol Neurosurg Psychiatry
, vol.77
, pp. 185-188
-
-
Kanesaka, T.1
Mori, M.2
Hattori, T.3
-
32
-
-
0034842248
-
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal-appearing white matter of multiple sclerosis
-
Lindberg RL, De Groot CJ, Montagne L, et al. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal-appearing white matter of multiple sclerosis. Brain 2001; 124: 1743-1753.
-
(2001)
Brain
, vol.124
, pp. 1743-1753
-
-
Lindberg, R.L.1
De Groot, C.J.2
Montagne, L.3
|